HKPD logo

Cellyan Biotechnology Co., Ltd Stock Price

NasdaqCM:HKPD Community·US$8.9m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

HKPD Share Price Performance

US$0.81
-2.01 (-71.39%)
US$0.81
-2.01 (-71.39%)
Price US$0.81

HKPD Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet and slightly overvalued.

2 Risks
1 Reward

Cellyan Biotechnology Co., Ltd Key Details

US$20.3m

Revenue

US$17.9m

Cost of Revenue

US$2.4m

Gross Profit

US$2.4m

Other Expenses

-US$27.1k

Earnings

Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
-0.0025
11.89%
-0.13%
37.6%
View Full Analysis

About HKPD

Founded
2023
Employees
27
CEO
Chenyu Liang
WebsiteView website
www.9zt.hk

Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.

Recent HKPD News & Updates

Recent updates

No updates